Cargando…
Antiviral activities of ISG20 in positive-strand RNA virus infections
ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-stra...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018280/ https://www.ncbi.nlm.nih.gov/pubmed/21036379 http://dx.doi.org/10.1016/j.virol.2010.10.008 |
_version_ | 1782196044866519040 |
---|---|
author | Zhou, Zhi Wang, Nan Woodson, Sara E. Dong, Qingming Wang, Jie Liang, Yuqiong Rijnbrand, Rene Wei, Lai Nichols, Joan E. Guo, Ju-Tao Holbrook, Michael R. Lemon, Stanley M. Li, Kui |
author_facet | Zhou, Zhi Wang, Nan Woodson, Sara E. Dong, Qingming Wang, Jie Liang, Yuqiong Rijnbrand, Rene Wei, Lai Nichols, Joan E. Guo, Ju-Tao Holbrook, Michael R. Lemon, Stanley M. Li, Kui |
author_sort | Zhou, Zhi |
collection | PubMed |
description | ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-strand RNA viruses from distinct viral families. ISG20 inhibited infections by cell culture-derived hepatitis C virus (HCV) and a pestivirus, bovine viral diarrhea virus and a picornavirus, hepatitis A virus. Moreover, ISG20 demonstrated cell-type specific antiviral activity against yellow fever virus, a classical flavivirus. Overexpression of ISG20, however, did not inhibit propagation of severe acute respiratory syndrome coronavirus, a highly-pathogenic human coronavirus in Huh7.5 cells. The antiviral effects of ISG20 were all dependent on its exonuclease activity. The closely related cellular exonucleases, ISG20L1 and ISG20L2, did not inhibit HCV replication. Together, these data may help better understand the antiviral specificity and action of ISG20. |
format | Text |
id | pubmed-3018280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-30182802012-01-20 Antiviral activities of ISG20 in positive-strand RNA virus infections Zhou, Zhi Wang, Nan Woodson, Sara E. Dong, Qingming Wang, Jie Liang, Yuqiong Rijnbrand, Rene Wei, Lai Nichols, Joan E. Guo, Ju-Tao Holbrook, Michael R. Lemon, Stanley M. Li, Kui Virology Article ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-strand RNA viruses from distinct viral families. ISG20 inhibited infections by cell culture-derived hepatitis C virus (HCV) and a pestivirus, bovine viral diarrhea virus and a picornavirus, hepatitis A virus. Moreover, ISG20 demonstrated cell-type specific antiviral activity against yellow fever virus, a classical flavivirus. Overexpression of ISG20, however, did not inhibit propagation of severe acute respiratory syndrome coronavirus, a highly-pathogenic human coronavirus in Huh7.5 cells. The antiviral effects of ISG20 were all dependent on its exonuclease activity. The closely related cellular exonucleases, ISG20L1 and ISG20L2, did not inhibit HCV replication. Together, these data may help better understand the antiviral specificity and action of ISG20. Elsevier Inc. 2011-01-20 2010-10-30 /pmc/articles/PMC3018280/ /pubmed/21036379 http://dx.doi.org/10.1016/j.virol.2010.10.008 Text en Copyright © 2010 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhou, Zhi Wang, Nan Woodson, Sara E. Dong, Qingming Wang, Jie Liang, Yuqiong Rijnbrand, Rene Wei, Lai Nichols, Joan E. Guo, Ju-Tao Holbrook, Michael R. Lemon, Stanley M. Li, Kui Antiviral activities of ISG20 in positive-strand RNA virus infections |
title | Antiviral activities of ISG20 in positive-strand RNA virus infections |
title_full | Antiviral activities of ISG20 in positive-strand RNA virus infections |
title_fullStr | Antiviral activities of ISG20 in positive-strand RNA virus infections |
title_full_unstemmed | Antiviral activities of ISG20 in positive-strand RNA virus infections |
title_short | Antiviral activities of ISG20 in positive-strand RNA virus infections |
title_sort | antiviral activities of isg20 in positive-strand rna virus infections |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018280/ https://www.ncbi.nlm.nih.gov/pubmed/21036379 http://dx.doi.org/10.1016/j.virol.2010.10.008 |
work_keys_str_mv | AT zhouzhi antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT wangnan antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT woodsonsarae antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT dongqingming antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT wangjie antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT liangyuqiong antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT rijnbrandrene antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT weilai antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT nicholsjoane antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT guojutao antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT holbrookmichaelr antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT lemonstanleym antiviralactivitiesofisg20inpositivestrandrnavirusinfections AT likui antiviralactivitiesofisg20inpositivestrandrnavirusinfections |